Related by context. All words. (Click for frequent words.) 73 Laquinimod 69 INCB# [001] 67 HuMax EGFr 67 teriflunomide 67 FTY# 67 Traficet EN 66 oral FTY# 66 RRMS patients 66 vidofludimus 65 NVA# 65 LymphoStat B 65 tocilizumab 65 Mipomersen 65 PRT# 65 BRIM2 65 PD LID 65 Plicera 65 AZILECT R 65 axitinib 64 relapsing remitting multiple sclerosis 64 HuMax CD# 64 phase IIb 64 Dasatinib 64 canakinumab 64 PEGylated interferon beta 1a 64 eltrombopag 64 DU #b 64 Phase 2a trial 64 ISIS # 64 phase IIa clinical 64 ZD# [001] 64 YONDELIS 64 safinamide 64 PROMACTA 64 BAY #-# 63 HuMax CD4 63 LY# [003] 63 PEG Interferon lambda 63 Tarceva TM 63 glatiramer acetate 63 ELND# 63 rilonacept 63 febuxostat 63 bendamustine 63 Alemtuzumab 63 ACZ# 63 Iloperidone 63 Natalizumab 63 placebo controlled clinical 63 COPAXONE R 63 ACTEMRA 63 Bortezomib 63 forodesine 63 Phase Ib study 63 PXD# 63 tezampanel 63 odanacatib 63 ZYBRESTAT 63 Fx #A 63 Golimumab 63 cilengitide 63 ATL/TV# 63 Phase Ib clinical 63 KRN# 63 phase 2a 63 antiplatelet agent 63 adalimumab 63 edoxaban 63 phase IIa 63 elotuzumab 63 phase IIb clinical 63 Triolex 62 Dapagliflozin 62 Catena ® 62 orally bioavailable 62 Fibrillex TM 62 oral prodrug 62 Tyrima 62 Pazopanib 62 Phase 1b 62 HQK 62 OHR/AVR# 62 RoACTEMRA 62 Glufosfamide 62 pomalidomide 62 Phase IIa clinical 62 PF # [001] 62 vicriviroc 62 refractory gout 62 regorafenib 62 MERLIN TIMI 62 Phase IIB 62 Phase IIb trials 62 R#/MEM # 62 Reverset 62 sunitinib malate 62 RRMS 62 Gabapentin GR 62 Phase 2a 62 Phase Ib 62 Betaferon R 62 registrational trial 62 CoFactor 62 HuLuc# 62 Phenoptin 62 Adalimumab 62 Safinamide 62 desvenlafaxine succinate 62 baminercept 62 PDE4 inhibitor 62 Archexin 62 Tavocept 62 IDX# 62 tapentadol ER 62 ataluren 62 rFIXFc 62 SCH # 62 albiglutide 62 nitazoxanide 62 angiogenesis inhibitor 62 bardoxolone methyl 62 6R BH4 62 huC# DM4 61 AZILECT ® 61 PRTX 61 decitabine 61 Carfilzomib 61 dyskinesia PD LID 61 mertansine 61 Teriflunomide 61 Amrubicin 61 investigational oral 61 aclidinium 61 Capesaris 61 CR# vcMMAE 61 nucleoside analog 61 Ophena TM 61 ganetespib 61 Ambrisentan 61 APEX PD 61 oral rivaroxaban 61 GSK# [001] 61 aclidinium bromide 61 NGX# 61 diabetic neuropathic pain 61 perifosine 61 Boceprevir 61 tanespimycin 61 vascular disrupting agent 61 Epratuzumab 61 telcagepant 61 daclizumab 61 Phase #/#a 61 selective modulator 61 quetiapine fumarate 61 TACI Ig 61 teduglutide 61 Fingolimod 61 Sym# 61 Phase IIIb clinical 61 albinterferon alfa 2b 61 lixisenatide 61 LAF# 61 rotigotine 61 lintuzumab 61 phase IIb trial 61 Serdaxin 61 riociguat 61 eprotirome 61 ThGRF 61 evaluating tivozanib 61 AEGR 61 Symadex 61 Lacosamide 61 INCB# [002] 61 fostamatinib 61 Desmoteplase 61 Betaferon ® 61 SNT MC# 61 investigational compound 61 RAPTIVA 61 ocrelizumab 61 neratinib 61 Elotuzumab 61 davunetide 61 Tolvaptan 61 interferon beta 1b 61 Vaprisol 61 methylnaltrexone 61 cannabinor 61 Phase 1b trial 61 Tanespimycin 61 CIMZIA ™ 61 ATL# [001] 61 EOquin TM 61 volociximab 61 Vandetanib 61 Lu AA# 61 opioid induced bowel dysfunction 61 ProSavin 61 VAPRISOL 61 ibandronate 61 atacicept 61 cediranib 61 selective androgen receptor modulator 60 Rasagiline 60 velafermin 60 XmAb# 60 OXi# 60 alvespimycin 60 Phase III ALLEGRO 60 RDEA# 60 Phase 2a clinical 60 Arcalyst 60 USL# 60 Zenvia 60 Febuxostat 60 alvimopan 60 alemtuzumab Campath 60 pramipexole 60 roflumilast 60 Aflibercept 60 uric acid lowering 60 sulodexide 60 GAMMAGARD 60 APOPTONE 60 calcitonin 60 BCX# 60 lacosamide 60 HGS ETR2 60 ospemifene 60 Vicriviroc 60 immunomodulatory 60 Azixa 60 Phase 1a clinical 60 ulimorelin 60 pertuzumab 60 Microplasmin 60 Phase IIa 60 abiraterone acetate 60 phase Ib 60 darapladib 60 TRIOLEX 60 ZOLINZA 60 Randomized Phase 60 relapsing multiple sclerosis 60 Relivar 60 etanercept 60 ACTEMRA TM 60 Etanercept 60 rFVIIIFc 60 S/GSK# 60 rasagiline 60 Cethromycin 60 ASA# 60 RhuDex 60 temsirolimus 60 JAK inhibitor 60 Tezampanel 60 SAR# [004] 60 CIPN 60 vandetanib 60 urocortin 2 60 APTIVUS r 60 administered subcutaneously 60 Rebif ® 60 Gattex 60 Pafuramidine 60 LY# [002] 60 AVONEX ® 60 MAP# 60 Syncria 60 Phase IIa trial 60 Tocilizumab 60 dexpramipexole 60 AGILECT R 60 PEGASYS ® 60 Phase 1a 60 Bicifadine 60 atrasentan 60 tiotropium 60 Rivaroxaban 60 TBC# 60 Pivotal Phase III 60 Tasimelteon 60 dacetuzumab 60 somatostatin analogue 60 Neurodex 60 Valortim 60 Campath alemtuzumab 60 Virulizin R 60 tasocitinib 60 tafamidis 60 Aurexis 60 postoperative ileus 60 Pirfenidone 60 Cetrorelix 60 HGS ETR1 60 Nuvion 60 Cloretazine R VNP#M 60 SEROQUEL XR 60 Asentar 60 eculizumab 60 Bezielle 60 sitaxsentan 60 Tesetaxel 60 mGluR5 NAM 60 romiplostim 60 Monotherapy 60 SRT# [003] 60 multicenter randomized placebo controlled 60 beta 1a 60 subcutaneously administered 60 romidepsin 60 Ofatumumab 60 REMICADE ® 60 Panzem R NCD 60 INCB# [003] 60 metaglidasen 60 DDP# 60 ascending dose 60 pan HDAC inhibitor 60 CG# [003] 60 ularitide 60 Mylotarg 60 Civacir 60 Rotigotine 59 antiepileptic drug 59 Parkinson disease levodopa induced 59 reslizumab 59 natalizumab 59 Hsp# Inhibitor 59 IRESSA 59 Zavesca ® 59 rufinamide 59 orally administered 59 abiraterone 59 Candesartan 59 arzoxifene 59 RG# [001] 59 Meets Primary Endpoint 59 oral salmon calcitonin 59 Daclizumab 59 VA# [002] 59 QNEXA 59 Phase Ib II 59 LUCENTIS 59 TMC# C# 59 placebo controlled Phase 59 trabedersen 59 pharmacokinetic PK 59 SIMPONI 59 Nexavar ® 59 MGCD# [001] 59 trodusquemine 59 TREANDA 59 ADAGIO study 59 NP2 Enkephalin 59 ritonavir boosted 59 RhuDex ® 59 desvenlafaxine 59 elagolix 59 GLYX 59 FTY# fingolimod 59 dirucotide 59 CGEN # 59 double blinded placebo 59 Phase III placebo controlled 59 rosuvastatin #mg 59 Xanafide 59 MAGE A3 ASCI 59 relapsed MM 59 apremilast 59 Cariprazine 59 QLT# 59 TRO# 59 ceftaroline 59 rilpivirine 59 low dose cytarabine 59 SUTENT 59 CBLC# 59 Torisel 59 immunomodulatory therapy 59 deforolimus 59 phase IIb study 59 carfilzomib 59 rasagiline tablets 59 sorafenib tablets 59 Phase IIb Trial 59 CCX# 59 entinostat 59 panitumumab Vectibix 59 Degarelix 59 sitagliptin 59 Quinamed 59 Apixaban 59 Emselex 59 TMC# [002] 59 Cethrin 59 Zerenex 59 TMC# [001] 59 telbivudine 59 EndoTAG TM -1 59 Hepatocellular Carcinoma HCC 59 Ceflatonin R 59 cathepsin K inhibitor 59 pegaptanib 59 enoximone 59 Tiotropium 59 OncoVEX GM CSF 59 Erlotinib 59 sorafenib Nexavar 59 ANYARA 59 Muraglitazar 59 Phase 2b Clinical Trial 59 polymerase inhibitor 59 XYOTAX TM 59 fingolimod 59 mTOR inhibitor 59 Eltrombopag 59 posaconazole 59 receptor inhibitor 59 Keryx Biopharma 59 PREOS 59 Dacogen injection 59 PKC# 59 Panzem R 59 Phase III 59 torezolid phosphate 59 delafloxacin 59 XL# [003] 59 tenofovir emtricitabine 59 pseudobulbar affect PBA 59 pharmacokinetic PK study 59 PEG SN# 59 fosbretabulin 59 CTAP# Capsules 59 SPRYCEL ® 59 Multaq R 59 diarrhea predominant irritable 59 Liraglutide 59 investigational protease inhibitor 59 dexanabinol 59 CDP# 59 Dalbavancin 59 Myelodysplastic Syndrome MDS 59 Linagliptin 59 alicaforsen enema 59 AEG# 59 abatacept 59 ZYBRESTAT fosbretabulin 59 rindopepimut 59 BARACLUDE R 59 severe gastroparesis 59 dose cohorts 59 efalizumab 59 RSD# oral 59 lasofoxifene 59 IPL# 59 Oral NKTR 59 bevacizumab Avastin 59 palonosetron 59 LB# [003] 59 Ophena 59 pharmacodynamic properties 59 Phase 2b study 59 MLN# 59 systemically administered 59 CRLX# 59 BRIM3 59 BAL# [002] 59 Lubiprostone 59 Azedra 59 cMET 59 proteasome inhibitor 59 Neulasta ® 59 Octreolin 59 Diabetic Macular Edema 59 Prestara 59 Trastuzumab 59 ramelteon 59 glucokinase activator 59 Phase III Clinical Trial 59 cariprazine 59 TYZEKA 58 ciclesonide 58 Clinical Trial Results 58 ancrod 58 ARCALYST 58 prucalopride 58 multicenter placebo controlled 58 Phase 2b clinical 58 elesclomol 58 aripiprazole 58 Virulizin ® 58 Actemra 58 Phase IIb trial 58 Vimpat ® 58 AP# [003] 58 tiotropium bromide 58 Pimavanserin 58 Telaprevir 58 ISENTRESS 58 rNAPc2 58 Phase 1b clinical 58 bicifadine 58 Leukine 58 MNTX 58 tgAAC# 58 ozarelix 58 Cimzia R 58 Egrifta 58 oral formulation 58 Relovair 58 solithromycin 58 eniluracil 58 pharmacodynamic PD 58 somatostatin analog 58 cangrelor 58 Campath ® 58 DAPT 58 cabazitaxel 58 EVIZON 58 GW# [003] 58 Aplidin R 58 fluvastatin 58 LymphoStat B belimumab 58 mycophenolate mofetil 58 crizotinib PF # 58 TELINTRA 58 visilizumab 58 VEGF inhibitors 58 small molecule Hedgehog 58 Voreloxin 58 Onbrez Breezhaler 58 MDV# 58 EDEMA3 58 cobiprostone 58 Phase IIIb 58 II Clinical Trial 58 STRIDE PD 58 novel oral anticoagulant 58 cancer cachexia 58 multicenter Phase III 58 RGB # 58 ruboxistaurin 58 Nanobody 58 ARCOXIA 58 lupus nephritis 58 Vitaxin 58 PREZISTA r 58 pegylated interferons 58 nucleotide analog 58 Ostarine 58 Kepivance 58 denufosol 58 mg BID 58 danoprevir 58 Actemra tocilizumab 58 MIRCERA 58 eosinophilic asthma 58 Aplidin 58 huN# DM1 58 registrational studies 58 Afatinib 58 chronic HCV infection 58 Milnacipran 58 Perifosine 58 investigational humanized monoclonal antibody 58 PSN# [002] 58 HCV protease inhibitor 58 Cimzia TM 58 Telbivudine 58 Elagolix 58 solanezumab 58 Fampridine 58 tezampanel NGX# 58 betrixaban 58 Saxagliptin 58 leukemia AML 58 Entereg R 58 oral cladribine 58 zanolimumab 58 MoxDuo IR 58 oral methylnaltrexone 58 golimumab 58 blinatumomab 58 JAK inhibitors 58 antibody MAb 58 pramlintide 58 receptor tyrosine kinase inhibitor 58 injectable formulation 58 tolvaptan 58 ToGA 58 Androxal TM 58 CCX# B 58 sunitinib 58 oral anticoagulant 58 Azilect ® 58 nalbuphine ER 58 PREOS R 58 castration resistant prostate cancer 58 mGluR2 positive 58 5 HT6 receptor 58 anti EGFR antibody 58 talactoferrin 58 TG# [003] 58 pregabalin 58 nab paclitaxel 58 Tofacitinib 58 rhIGF-I/rhIGFBP-3 58 brivaracetam 58 Alzhemed TM 58 hypercalcemia 58 BRAF inhibitor 58 post menopausal osteoporosis 58 erlotinib Tarceva 58 Phase IIb 58 anakinra 58 NUVIGIL 58 Factor VIIa 58 Guanilib 58 relapsed myeloma 58 Cladribine Tablets 58 CIMZIA TM 58 olmesartan 58 clobazam 58 Tamibarotene 58 dabigatran etexilate 58 Pharmacokinetic PK 58 lubiprostone 58 randomized discontinuation trial 58 dose cohort 58 linaclotide 58 GALNS 58 KNS # 58 INT# [002] 58 PROSTVAC TM 58 Fabry Disease 58 ImmunoVEX HSV2 58 anti amnesic 58 metastatic castration resistant 58 IMGN# 58 AeroLEF TM 58 zoledronic acid 58 Cimzia ® certolizumab pegol 58 Pemetrexed 58 APTIVUS 58 anti leukemic 58 ribavirin Copegus 58 CYT# potent vascular disrupting 58 Diamyd ® 58 beta interferons 58 Phase IIb clinical 58 goserelin 58 Aptivus ® 58 ixabepilone 58 ARIKACE 58 Ocrelizumab 58 TNF inhibitor 58 ONCONASE 58 Arikace 58 ritonavir boosting 58 Vfend 58 inhaled iloprost 58 Betaferon 58 vorinostat 58 depsipeptide 58 zileuton 58 MEND CABG 58 metastatic RCC 58 intravenous dosing 58 AVOREN 58 TYKERB 58 Cloretazine ® 58 rivaroxaban 58 gefitinib 58 anticancer compound 58 Amplimexon 58 oral Xeloda 58 enzastaurin 58 Bapineuzumab 58 ADX# 58 relapsed multiple myeloma 58 Benlysta belimumab 58 ranolazine 58 Excellarate TM 57 Dual Opioid 57 ORENCIA ® 57 Panitumumab 57 Pivotal Phase 57 orally dosed 57 ziprasidone Geodon 57 aplindore 57 SANTE 57 asenapine 57 EURIDIS 57 mipomersen 57 Systemic Juvenile Idiopathic 57 acetonide FA 57 PI3K/Akt pathway inhibitor 57 QD dosing 57 Arranon 57 ONCONASE R 57 lumiliximab 57 Phase 2b trial 57 Genz # 57 Locteron 57 lomitapide 57 Atrasentan 57 lurasidone 57 Pertuzumab 57 mg doses 57 Pyridorin 57 azacitidine 57 TNF Tumor Necrosis Factor 57 tesofensine 57 FOLOTYN ® 57 octreotide acetate 57 dosing cohort 57 Phase Ib clinical trials 57 Imprime PGG 57 vismodegib 57 perampanel 57 muraglitazar 57 liposomal formulation 57 R#/MEM 57 relapsing MS 57 radiation sensitizer 57 ongoing Phase 1b 57 Initiate Phase 57 COPAXONE ® 57 Oral Fingolimod 57 Naproxcinod 57 StemEx 57 AZD# 57 senicapoc 57 Amigal 57 galiximab 57 Tarceva erlotinib 57 Spheramine 57 Omnitarg 57 teriparatide 57 Phase IIa trials 57 NEVO ™ 57 Alpharadin 57 Pralatrexate 57 HGS# 57 amifostine 57 LUX Lung 57 KB# [002] 57 PROVENGE ® 57 pioglitazone 57 Preclinical studies 57 viral kinetic 57 TRX1 57 MYDICAR ® 57 TELCYTA 57 iniparib 57 IMA# 57 Pharmacokinetics PK 57 ADP receptor antagonist 57 paclitaxel poliglumex 57 atypical antipsychotic 57 Phase IIA 57 PSMA ADC 57 CYC# 57 invasive candidiasis 57 mGluR2 NAM 57 Phase 2a Clinical Trial 57 Long Term Efficacy 57 Tarvacin 57 subcutaneous formulation 57 TASKi2 57 bosentan 57 Vidofludimus 57 recurrent glioblastoma multiforme 57 Denosumab 57 Acapodene 57 GRN# 57 R roscovitine 57 L BLP# 57 cetrorelix 57 TASQ 57 Exenatide 57 ROCKET AF 57 budesonide foam 57 interferon alfa 57 PEG INTRON 57 Angiolix 57 favorable pharmacokinetic profile 57 nilotinib 57 confirmatory Phase III 57 8mg/kg 57 oral proteasome inhibitor 57 Protelos 57 Menerba 57 placebo controlled trials 57 antiviral efficacy 57 Clevudine 57 CORT # 57 aripiprazole Abilify 57 BOLDER II 57 anastrozole 57 ALKS 57 #th Annual Interscience 57 PRECiSE 57 CEQ# 57 serum phosphate 57 tesetaxel 57 otelixizumab 57 YONDELIS R 57 CYT# 57 VELCADE melphalan 57 FOLOTYN 57 systemic juvenile idiopathic 57 CD# monoclonal antibody 57 inhibit metastasis 57 DAVANAT 57 Vernakalant 57 exenatide 57 R sorafenib tablets 57 Clolar ® 57 histone deacetylase HDAC inhibitor 57 DEB# 57 placebo controlled randomized 57 Azilect 57 octreotide LAR 57 amrubicin 57 ANAVEX #-# [003] 57 OPAXIO 57 Neovascular AMD 57 Phase IIb Clinical Trial 57 Phase III Clinical Trials 57 NMDA antagonist 57 sipuleucel T 57 custirsen 57 oral ridaforolimus 57 Benign Prostatic Hyperplasia 57 Altastaph 57 Serdolect ® 57 CCR5 antagonist 57 midstage clinical 57 celgosivir 57 bazedoxifene 57 divalproex sodium 57 Metastatic Melanoma 57 pain palliation 57 olaparib 57 ULORIC 57 viral kinetics 57 Sapacitabine 57 idebenone 57 trastuzumab emtansine T DM1 57 Enzastaurin 57 ILUVIEN ® 57 dose escalation Phase 57 CD3 monoclonal antibody 57 Thalomid ® 57 CCR5 mAb 57 DermaVir Patch 57 pegylated liposomal doxorubicin 57 preclinical efficacy 57 Valdoxan 57 Allovectin 7 R 57 MGd 57 abacavir lamivudine 57 TOLAMBA 57 glufosfamide 57 paliperidone palmitate 57 olanzapine Zyprexa 57 systemic lupus erythematosus SLE 57 icatibant 57 Taxotere ® 57 CA4P 57 pharmacokinetic PK profile 57 Lodotra 57 Ranolazine 57 interferon gamma 1b 57 Medidur TM FA 57 humanized monoclonal antibody 57 noninfectious uveitis 57 vemurafenib 57 neurogenic orthostatic hypotension 57 SERMs 57 LEVADEX 57 ANG# 57 Exelixis XL# 57 bortezomib Velcade 57 Omacetaxine 57 tipranavir 57 MIRAPEX ER 57 tiapamil 57 SYN# 57 Unit Dose Budesonide 57 maximally tolerated dose 57 TREDAPTIVE 57 LUMINATE 57 mGluR5 negative 57 iclaprim 57 GRNCM1 57 gefitinib Iressa 57 TOCOSOL Paclitaxel 57 BENLYSTA ® 57 SHPT 57 CIMZIA R 57 azilsartan medoxomil 57 GAMMAGARD LIQUID 57 MBP# dirucotide 57 integrase inhibitor 57 Inhalation Solution 57 AVE# 57 IFN α 57 CaPre TM 57 PCK# 57 ITAX 57 raltegravir 57 Glatiramer Acetate 57 #mg dose [001] 57 ATACAND 57 tolerability profiles 57 lorvotuzumab mertansine 57 Pegasys ® 57 TRANSFORMS 57 orBec 57 peripherally acting 57 omecamtiv mecarbil 57 tranilast 57 QVA# 57 HCV protease inhibitors 57 ximelagatran 57 Alocrest 57 NXL# 57 VEGF Trap Eye 57 randomized Phase III 57 ambrisentan 57 pediatric malignancies 57 paliperidone ER 57 TPI ASM8 57 IPX# 57 Novel Oral 57 Intervention Effectiveness 57 Ozarelix 57 ON #.Na 57 radezolid 57 sapacitabine 57 Diabetic Neuropathy 57 milatuzumab 57 Clonicel 57 afatinib 57 GFT# 57 Abiraterone acetate 57 RSD# 57 Troxatyl 57 tramiprosate Alzhemed TM 57 Rilonacept 57 R# #mg BID 57 ENMD # 57 Pharmacokinetic 57 hyperphenylalaninemia HPA due 57 registrational 57 MEK inhibitors 57 Interferon alpha 57 IIa trial 57 multi kinase inhibitor 57 ABSORB trial 57 Prostate AdenoCarcinoma Treatment 57 ocular hypertension 57 immune modulatory 57 IFN beta 57 LEUKINE 57 coadministration 57 PEGylated Fab fragment 56 NM# [003] 56 Ceflatonin 56 multicentre randomized 56 evaluating REVLIMID 56 Hydroxyurea 56 Acute Ischemic Stroke 56 CYT# QbG# 56 VPRIV 56 cancer neuroendocrine tumor 56 Telintra 56 SAR# [002] 56 Rosuvastatin 56 Neupogen ® 56 aprepitant 56 AGILECT ® 56 OZURDEX ® 56 cilostazol 56 GetGoal Phase III 56 GATTEX TM 56 MEK inhibitor 56 Cinquil 56 preclinically 56 Free Survival PFS 56 insulin degludec 56 TEMODAL 56 cholinesterase inhibitors